IRB Study Number 21-179
Status Recruiting
Phase Not Applicable
Location U Building - Mellen Center
Institute Neurological Institute
Description
The purpose of this study is to determine MRI biomarkers, describe unique MRI features, and determine clinical and MRI predictors of clinical outcomes of myelin oligodendrocyte glycoprotein antibody (MOG-IgG1) associated disorders (MOGAD). This will help characterize the MRI features of MOGAD, and differentiate these from aquaporin-4 (AQP4-IgG) neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosis (MS).
Participants will be asked to complete one visit. Activities include a 7T MRI scan with or without contrast and optional blood sample collection.
Inclusion Criteria
- Age 18-99 years
- Diagnosis of MOGAD, multiple sclerosis (MS) or are a healthy control
Exclusion Criteria
- Contraindication to MRI scans
